Therapy Areas: Infectious Diseases
18 September 2018 - - US-based clinical-stage biotechnology company AmpliPhi Biosciences Corp. (NYSE American: APHB) had a Type B Pre-IND meeting with the US Food and Drug Administration and has now r...
17 September 2018 - - UK-based biologicals developer Virion Biotherapeutics has appointed Vanessa King, PhD, as president and chief executive officer and Isabel Najera, PhD, as chief scientific office...
13 September 2018 - - US-based biotechnology vaccines developer TechnoVax, Inc has received a two-year USD 1.481m SBIR-II grant from the National Institute of Allergy and Infectious Diseases (NIAID) o...
12 September 2018 - - Jersey-based oncology company Novocure (NASDAQ: NVCR) and China-based biopharmaceutical company Zai Lab (NASDAQ: ZLAB) have inked an exclusive license agreement for Tumor Treatin...
12 September 2018 - - US-based small molecule drug developer DesignMedix's lead product, experimental anti-malaria medicine DM1157, has begun human clinical trials, the company said.

...
11 September 2018 - - Apivotal Phase 3 clinical study evaluating US-based pharmaceutical company Merck and Co., Inc.'s (NYSE: MRK) antibiotic Zerbaxa (ceftolozane and tazobactam) at an investigat...